Innovation at Penn
Browse Penn-owned technologies available for licensing.
Search Results - reynold panettieri
Pharmaceutical therapeutic for the treatment of respiratory diseases
Histone deacetylase (HDAC) inhibitors such as Trichostatin A to treat bronchoconstrictive diseases including asthma and chronic obstructive pulmonary disorder (COPD) Technology Overview: Asthma and COPD are diseases of variable airflow obstruction affecting more than 40 million Americans. Although some patients respond to conventional therapies,...
Therapeutics & Vaccines
© 2020. All Rights Reserved. Powered by